Organovo Logo     Print Page | Close Window

Investor Overview

Who is Organovo?
  • We participate in attractive and growing markets with critical unmet needs
  • We benefit from favorable competitive dynamics and a first mover advantage
  • We’re a technology leader with a strong IP portfolio
  • We’re leveraging our technology platform to build a robust product and service platform across the preclinical safety, efficacy and disease modeling and therapeutic tissues markets
2017 Annual Report Investor Fact Sheet Investor Presentation

Stock Information
ONVO (Common Stock)
ExchangeNASDAQ (US Dollar)
Change (%) - 0.05 (2.11%)
Data provided by Nasdaq. Minimum 15 minutes delayed.
Stock chart for: ONVO.O.  Currently trading at $2.32 with a 52 week high of $4.99 and a 52 week low of $2.30.
Recent Investor News
Organovo Announces Release Date for Fiscal First-Quarter 2018 Financial Results
Organovo Announces Fiscal Fourth-Quarter and Full-Year 2017 Results; Company Issues Full-Year Fiscal 2018 Outlook
Investor Events
Wednesday, August 9, 2017 5:00 p.m. ET
Q1 2018 Organovo Holdings Inc Earnings Conference Call
Featured Reports
2017 Annual Report
2017 Proxy Statement
Latest Tweets